Tech Company Financing Transactions
Valerion Therapeutics Funding Round
Valerion Therapeutics, based in Concord, raised $20 million from private investors.
Transaction Overview
Company Name
Announced On
3/6/2012
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will be used to support the continued development of a proprietary antibody technology that provides targeted and active intracellular delivery of active proteins, enzymes and other macromolecules to skeletal muscle.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Main St. 110
Concord, MA 01742
USA
Concord, MA 01742
USA
Phone
Website
Email Address
Not Recorded
Overview
Valerion Therapeutics is utilizing a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a well-known and broadly studied transport pathway.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Deborah Ramsdell
Chief Medical Officer
Hal Landy
Chief Scientific Officer
Dustin Armstrong
Browse more venture capital transactions:
Prev: 3/6/2012: Aragon Pharmaceuticals venture capital transaction
Next: 3/7/2012: Aponia Laboratories venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs